Vanda Pharmaceuticals
VNDA
#7499
Rank
โ‚ฌ0.27 B
Marketcap
4,72ย โ‚ฌ
Share price
0.82%
Change (1 day)
49.24%
Change (1 year)

Revenue for Vanda Pharmaceuticals (VNDA)

Revenue in 2024 (TTM): โ‚ฌ0.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.17 Billion. In 2023 the company made a revenue of โ‚ฌ0.17 Billion a decrease over the revenue in the year 2022 that were of โ‚ฌ0.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vanda Pharmaceuticals from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.16 B-3.22%
2023 โ‚ฌ0.17 B-26.52%
2022 โ‚ฌ0.23 B-0.04%
2021 โ‚ฌ0.23 B17.59%
2020 โ‚ฌ0.20 B-0.51%
2019 โ‚ฌ0.20 B20.14%
2018 โ‚ฌ0.16 B22.69%
2017 โ‚ฌ0.13 B-0.89%
2016 โ‚ฌ0.13 B38.08%
2015 โ‚ฌ0.10 B143.78%
2014 โ‚ฌ41.23 M68.11%
2013 โ‚ฌ24.53 M-0.85%
2012 โ‚ฌ24.74 M2.75%
2011 โ‚ฌ24.07 M-10.31%
2010 โ‚ฌ26.84 M745.76%
2009 โ‚ฌ3.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ47.67 B 27,336.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ39.00 B 22,349.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.71 B 48,078.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.28 B 25,960.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ53.11 B 30,468.83%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ59.64 B 34,224.97%๐Ÿ‡บ๐Ÿ‡ธ USA